Revenue Growth (YoY)
Updated 32h ago
Sector Performance
18th percentileCPRT
2.1%
Sector Median
7.9%
Sector Avg
11.7%
Deep Analysis
Revenue growth (year-over-year, or YoY) measures how much a company’s sales increased or decreased compared to the same quarter last year.
CPRT’s current 2.1% YoY growth is well below the sector median of 7.9%, placing the company in the 18th percentile among its peers. The YoY change is not applicable because only one period of data is provided, and the quarter-over-quarter change is also not available. The lack of trend data means you cannot assess whether growth is accelerating or slowing, which limits visibility into recent momentum. Combined with a low absolute growth rate relative to peers, this creates a below-average revenue performance that raises caution. This metric supports the overall NEUTRAL verdict because the weak growth level, while not alarming, offers no positive catalyst to upgrade the stock, yet the absence of a downward trend prevents a bearish downgrade.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about CPRT?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are CPRT's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: COP (-4.6%), CCI (-4.8%), EMN (-4.9%), IPG (-5.1%), LEN (-5.2%).
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master CPRT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CPRT research report →CPRT
2.1%
Sector Median
7.9%
Sector Avg
11.7%
How CPRT's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.